Delivery Order SPE2DB22D2005-SPE2DB25FJKK9

Award Date 3/28/25
Potential Completion Date 4/18/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the VARIVAX vaccine with diluents. The contract has a ceiling value of $1,032.11 and a period of performance through March 7, 2025. The contract is a firm-fixed-price delivery order and was not set aside for any specific business size or type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $9,370.10 and a completion date of October 9, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $3,159.03 and a performance period through May 13, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the VARIVAX vaccine with diluents. The contract has a ceiling value of $10,321.10 and is a firm fixed-price, non-set-aside contract with a performance period ending on May 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $2,867.91 and a completion date of August 13, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARIVAX vaccine with diluents, with a ceiling value of $233,533.44 and a performance period ending on June 9, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $2,064.22 and runs through March 19, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corporation. The contract is for the delivery of VARIVAX vaccine with diluents, with a ceiling value of $1,911.94 and a period of performance through October 7, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor that holds several...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $8,256.88 and a period of performance through March 24, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VARIVAX vaccine with diluents, with a ceiling value of $1,053.01 and a period of performance through February 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJKK9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $1,032.11 and a period of performance ending on April 18, 2025. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/27/25, 12:19 PM